Malaysian company will market Cuban vaccine against cancer

The drug is a kind of immunotherapy aimed at proteins called epidermal growth factor, overexpressing cancer cells, and in his last test phase over four hundred patients from ten countries participated.

http://www.radiohc.cu/uploads/images/articulos/7596-vacuna.jpg

La empresa Malasia de biotecnología Bioven, que realiza ensayos clínicos de Fase III de una prometedora vacuna cubana contra el cáncer de pulmón, planea cotizar en Londres tras una fructífera colaboración con La Habana.

Explicó Elnartd Blanco, gerente comercial del Cimab, entidad comercializadora del Centro de Inmunología Molecular de Cuba, que desde 2008, Bioven realiza mediante un acuerdo el desarrollo clínico del fármaco en Europa y parte de Asia y Oceanía.

View original post 82 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s